相关实验视频
Updated: Jun 29, 2025

06:39
Real-Time Void Spot Assay
Published on: February 10, 2023
2.0K
在患有过度活性膀综合征的妇女中,非持续性预测因素
Sheng-Mou Hsiao1,2,3
1Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, No. 21, Sec. 2, Nanya S. Rd., Banqiao Dist., New Taipei City, Taiwan. smhsiao2@gmail.com.
Scientific reports
|March 30, 2024
概括
与solifenacin相比,Mirabegron显示出较高的持续率和较少的药物切换对于过度活跃的膀 (OAB). 高龄和更高的空化量预测增加药物,而低平价和低的失禁影响问卷得分表明没有药物的改善.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 药理学 药理学是指药理学的学科.
- 妇女健康 妇女健康
背景情况:
- 治疗的坚持对于管理女性过度活动膀 (OAB) 综合征至关重要.
- 首线医疗治疗,如索利费纳和米拉贝格朗,通常用于OAB.
- 识别治疗不持续性的预测因素对于优化患者的治疗结果至关重要.
研究的目的:
- 确定影响OAB患者接受一线医疗治疗的女性不持续性因素.
- 为了比较solifenacin和mirabegron之间的持久率和药物切换行为.
- 为了确定与需要额外药物治疗或没有药物治疗的改善相关的患者特征.
主要方法:
- 对608名经过尿动力学研究的OAB女性进行了回顾性审查.
- 对接受5毫克索利费纳辛或25毫克米拉贝格朗作为一线治疗的患者的分析.
- 使用危险比率 (HR) 进行统计分析,以确定非持续性,药物切换和治疗增强的预测因素.
主要成果:
- 与solifenacin相比,Mirabegron与明显更高的持续率 (HR=0.711) 有关.
- 米拉贝格朗治疗降低了改变药物的可能性 (HR=0.269),而高的泌尿生殖器应激清单得分增加了它 (HR=1.082).
- 年龄较大 (≥75岁) 和高空体积 (≥250毫升) 预测需要额外的药物,而低平价 (≤3) 和低失禁影响问卷得分 (≤7) 与没有药物的改善有关.
结论:
- 米拉贝格朗是治疗过度活跃膀的第一线治疗选择,与索利费纳相比,增强了治疗的持续性和减少了药物切换.
- 考虑组合疗法或更高剂量的单一疗法可能对老年患者 (≥75岁) 或具有大量空化体积 (≥250毫升) 的患者有益.
- 患者的特征,如平价和症状影响评分,可以指导治疗策略,并预测治疗反应.
相关概念视频
Disorders of the Urinary System
298
The urinary system is responsible for eliminating waste and excess fluids from the body. However, disorders of the urinary system can arise due to various reasons like infections, stress, age, congenital abnormalities, and lifestyle.
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
298
Irritable Bowel Syndrome III: Medical and Nursing Management
201
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
201
Irritable Bowel Syndrome I: Introduction
272
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
272
Drugs for Treatment of Diarrhea-Predominant IBS
166
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
166
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
159
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
159
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357

